BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35813221)

  • 21. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

  • 22. Signal peptidase 21 suppresses cell proliferation, migration, and invasion via the PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma.
    Zhang N; Cao S; Sun R; Wang Y; Liu L; Wang W; Meng X
    PeerJ; 2022; 10():e14206. PubMed ID: 36275477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADAM12 promotes the resistance of lung adenocarcinoma cells to EGFR-TKI and regulates the immune microenvironment by activating PI3K/Akt/mTOR and RAS signaling pathways.
    Li K; Quan L; Huang F; Li Y; Shen Z
    Int Immunopharmacol; 2023 Sep; 122():110580. PubMed ID: 37418984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
    Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
    Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway.
    Zhang J; Wang J; Yue K; Li P; Shen W; Qiao X; Wang Y; Wu X
    BMC Pulm Med; 2023 Jan; 23(1):32. PubMed ID: 36690987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [S100A10 promotes proliferation and invasion of lung adenocarcinoma cells by activating the Akt-mTOR signaling pathway].
    Wang H; Sun Z; Zhao W; Geng B
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 May; 43(5):733-740. PubMed ID: 37313814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of SFXN1 indicates poor prognosis and promotes tumor progression in lung adenocarcinoma.
    Chen L; Kang Y; Jiang Y; You J; Huang C; Xu X; Chen F
    Pathol Res Pract; 2022 Sep; 237():154031. PubMed ID: 35878532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TIMELESS promotes the proliferation and migration of lung adenocarcinoma cells by activating EGFR through AMPK and SPHK1 regulation.
    Yin H; Wang Z; Wang D; Nuer M; Han M; Ren P; Ma S; Lin C; Chen J; Xian H; Ai D; Li X; Ma S; Lin Z; Pan Y
    Eur J Pharmacol; 2023 Sep; 955():175883. PubMed ID: 37433364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UHMK1 promotes lung adenocarcinoma oncogenesis by regulating the PI3K/AKT/mTOR signaling pathway.
    Li Y; Wang S; Jin K; Jin W; Si L; Zhang H; Tian H
    Thorac Cancer; 2023 Apr; 14(12):1077-1088. PubMed ID: 36919755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular 5'-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3β/β-catenin/cyclinD1 signaling pathway.
    Yu J; Wang X; Lu Q; Wang J; Li L; Liao X; Zhu W; Lv L; Zhi X; Yu J; Jin Y; Zou Q; Ou Z; Liu X; Zhou P
    Int J Cancer; 2018 Mar; 142(5):959-967. PubMed ID: 29047106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis.
    Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H
    Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sec61γ is a vital protein in the endoplasmic reticulum membrane promoting tumor metastasis and invasion in lung adenocarcinoma.
    Xu S; Li X; Geng J; Cao Y; Yu Y; Qi L
    Br J Cancer; 2023 Apr; 128(8):1478-1490. PubMed ID: 36759724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GLUT1 promotes cell proliferation via binds and stabilizes phosphorylated EGFR in lung adenocarcinoma.
    Zhou Z; Li Y; Chen S; Xie Z; Du Y; Liu Y; Shi Y; Lin X; Zeng X; Zhao H; Chen G
    Cell Commun Signal; 2024 Jun; 22(1):303. PubMed ID: 38831321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
    Wang Y; Mei X; Song W; Wang C; Qiu X
    BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
    FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S; Wang X; Zhang Z; Liu D
    Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma.
    Ma G; Yang L; Dong J; Zhang L
    Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GALNT2 promotes cell proliferation, migration, and invasion by activating the Notch/Hes1-PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma.
    Wang W; Sun R; Zeng L; Chen Y; Zhang N; Cao S; Deng S; Meng X; Yang S
    Life Sci; 2021 Jul; 276():119439. PubMed ID: 33785338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [ANXA8 Regulates Proliferation of Human Non-Small Lung Cancer Cells A549 via EGFR-AKT-mTOR Signaling Pathway].
    Zhou GZ; Sun YH; Shi YY; Zhang Q; Zhang L; Cui LQ; Sun GC
    Mol Biol (Mosk); 2021; 55(5):870-880. PubMed ID: 34671007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma.
    Rocha P; Salazar R; Zhang J; Ledesma D; Solorzano JL; Mino B; Villalobos P; Dejima H; Douse DY; Diao L; Mitchell KG; Le X; Zhang J; Weissferdt A; Parra-Cuentas E; Cascone T; Rice DC; Sepesi B; Kalhor N; Moran C; Vaporciyan A; Heymach J; Gibbons DL; Lee JJ; Kadara H; Wistuba I; Behrens C; Solis LM
    Cancer Immunol Immunother; 2021 Jul; 70(7):1965-1976. PubMed ID: 33416944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.